Tulipano Stephen J has filed 5 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 60000 shares of Stoke Therapeutics, Inc. ($STOK) on March 27, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2024 | Stoke Therapeutics, Inc. | $STOK | Tulipano Stephen J | Former CFO | A | Employee Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 43,994,862 | 9999.99% | 0.14% |
| March 27, 2024 | Stoke Therapeutics, Inc. | $STOK | Tulipano Stephen J | Former CFO | A | Restricted Stock Units | 40000 | $0.00 | 40,000.0000 | 43,994,862 | 9999.99% | 0.09% |
| March 15, 2024 | Stoke Therapeutics, Inc. | $STOK | Tulipano Stephen J | CFO | M | Common Stock | 13100 | $0.00 | 24,862.0000 | 43,994,862 | 111.38% | 0.03% |
| March 19, 2024 | Stoke Therapeutics, Inc. | $STOK | Tulipano Stephen J | CFO | S | Common Stock | 4116 | $6.10 | 20,746.0000 | 43,994,862 | 16.56% | 0.01% |
| March 15, 2024 | Stoke Therapeutics, Inc. | $STOK | Tulipano Stephen J | CFO | M | Restricted Stock Units | 13100 | $0.00 | 39,300.0000 | 43,994,862 | 25.00% | 0.03% |